Several CRYOSTEM players are participating in the 48th EBMT annual meeting. Here is a selection of posters and presentations that will be held as part of the scientific program:
Dr. Eolia Brissot, member of the CRYOSTEM Scientific Committee:
Monday, March 21, 09:00 – 10:00 – E1 AML and allogeneic HCT: for whom, how, and when? Chair
Wednesday, March 23, 12:15 – 13:30 – OS16 Oral session 16: Conditioning Chair
Monday, March 21, 09:00 – 10:00 E1-05 Conclusions Speaker
Tuesday, March 22, 09:00 – 10:15 ALWP-05 Role of bispecific antibodies Speaker
Wednesday, March 23, 10:45 – 12:00 OS12-07 CD34+ DOSE EFFECTS ON CLINICAL OUTCOMES AFTER FLUDARABINE-BUSULFAN CONDITIONING REGIMEN FOR ACUTE MYELOID LEUKEMIA USING PERIPHERAL BLOOD STEM CELLS – STUDY FROM THE ALWP OF EBMT Oral Presenter
Sunday, March 20, 08:30 – 10:00 IS03-04 CAR-T cells in ALL Speaker
Pr. Frédéric Baron, member of the CRYOSTEM Scientific Committee:
Tue, March 22, 14:15 – 15:30 – P2 Optimisation of transplant outcome by modifiable pre- and peri-transplant variables Chair
Wednesday, March 23, 10:45 – 12:00 – OS12 Oral session 12: Acute leukemia Chair
Saturday, March 19, 09:50 – 18:00 – P170 HLA-MISMATCHED UNRELATED DONOR TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE VERSUS HLA-HAPLOIDENTICAL TRANSPLANTATION IN PATIENTS WITH ACTIVE ACUTE MYELOID LEUKEMIA Poster Presenter
Saturday, March 19, 09:50 – 18:00 – P509 HLA-HAPLOIDENTICAL TRANSPLANTATION WITH PTCY IN AML PATIENTS WITH ACTIVE DISEASE AT TRANSPLANTATION: BETTER SURVIVAL WITH BM THAN WITH PBSC IN PATIENTS > 55 YEARS Poster Presenter
Saturday, March 19, 09:50 – 18:00 – P308 THIRD-DOSE BNT162B2 VACCINE IS HIGHLY EFFICIENT AT INCREASING ANTI-RBD SARS-COV-2 IGG TITERS IN ALLO-HCT RECIPIENTS Poster Presenter
Dr. David Michonneau, member of the CRYOSTEM Strategic Committee :
Wednesday, March 23, 10:45 – 12:00 – OS14 Oral session 14: GVHD II, clinical and preclinical Chair
Saturday, March 19, 09:50 – 18:00 – P216 CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (ALLO-HSCT) IN FRANCE Poster Presenter
Dr. Marie Robin, member of the CRYOSTEM Strategic Committee:
Monday, March 21, 16:15 – 17:30 – OS03 Oral session 3: Various diseases: myeloproliferative neoplasm and myelodysplastic syndrome Chair
Tuesday, March 22, 16:00 – 17:00 – E10-03 Current transplant algorithm for MDS Speaker
Pr. Jean-Hugues Dalle, vice President of CRYOSTEM:
Sunday, March 20, 08:30 – 10:00 – IS02 Allogeneic hematopoietic stem cell transplantation for non-malignant haematological disease | SFGM-TC- Non profit Symposium Chair
Tuesday, March 22, 14:15 – 15:30 Paed3 Paediatric Diseases Oral Session Chair
Dr. Thomas Luft, project leader supported by CRYOSTEM:
Tuesday, March 22, 10:45 – 11:45 E8-02 Endothelial dysfunction in aGVHD Speaker
Tuesday, March 22, 10:45 – 12:00 HDI5-02 How do we use biomarkers? Speaker